Last week, the Financial Times carried on its front page an article emphasising the extent to which the European Medicines Agency, when it was based at Canary Wharf, leaned on our MHRA for assistance with much of its work. It has also faced very real challenges, at least from the FT evidence, since the relocation to Amsterdam because so many senior staff have not wanted to relocate from London. Would the Counsel General support and can he see any way perhaps that our regulators might be able to offer mutual aid and support to the EMA to support them in the regulatory requirements they need to fulfil for the European Union, hopefully, to speed up vaccines for them as well as for us?